During 14-16 March 2021, 4th World Congress and Expo on Traditional and Alternative Medicine is organized in collaboration with Taipei Chinese Medical Association, Meridian World Health Organization Alliance (MWHOA), Chang Gung University, Tzu Chi University, I Shou University, and China Medical University. The Congress focused on the theme “World Health for everyone with local Wisdom and Resources,” with the domestic well-known speakers and international scholars were invited to publish the research of traditional and alternative medical therapies for global health issues through this online conference. The Head of Technology of SunWay Biotech, Dr. Tzu-Ming Pan, was invited as a speaker by Taipei Chinese Medical Association and Global Scientific Guild to announce at the conference that heart health supplement plays an important role for global health. According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are the leading cause of death globally. WHO says that about 17.9 million people worldwide died from CVDs in 2016 alone, representing 31 percent of all global deaths. Moreover, amid the COVID-19 crisis, the global market for Heart Healthy Ingredients estimated at US$16.6 Billion in the year 2020, is projected to reach a revised size of US$24.8 Billion by 2027, growing at a of 5.9% over the analysis period 2020-2027. Red yeast rice, as a dietary supplement ingredient for heart health, is prized for its ability to lower cholesterol […]

The red yeast rice raw material ANKASCIN 568-R, manufactured by SunWay Biotech Co., Ltd. (herein after “SunWay”), undergoes a rigorous production process. Here below are the key points SunWay declares:   Local Rice Sourcing: The fermentation white rice used in ANKASCIN 568-R is sourced from local Taiwanese rice merchants through contractual agreements. This ensures traceability and quality control. Exclusive Patented Solid-State Fermentation Process: The unique patented solid-state fermentation process is employed during production. Certifications and Compliance: The production facility in Taiwan adheres to the Good Manufacturing Practice for Health Supplements (GMP) standards set by the Taiwan Food and Drug Administration. And SunWay holds GMP certification. SunWay also holds ISO22000 and HACCP certifications. The entire production process takes place in a sterile, closed, and fully automated fermentation facility. No external red yeast rice raw materials are added, eliminating concerns about blending with materials from other sources, including Japanese manufacturers like Kobayashi Pharmaceutical Company Ltd. Human Clinical Trials and Safety Monitoring: ANKASCIN 568-R has undergone multiple human clinical trials. Safety indicators have been monitored in over 200 participants, confirming its safety for liver and kidney function. It is the only red yeast rice product to receive New Dietary Ingredients (NDI) certification from the U.S. FDA, allowing it to legally indicate the content of active ingredients and be sold in the U.S. Stringent […]